Sulfadiazine: Difference between revisions
Jump to navigation
Jump to search
| Line 16: | Line 16: | ||
''' [[Sulfadiazine description|Description]]''' | ''' [[Sulfadiazine description|Description]]''' | ||
'''| [[Sulfadiazine clinical pharmacology|Clinical Pharmacology]]''' | '''| [[Sulfadiazine clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[Sulfadiazine indications and usage|Indications and Usage]]''' | '''| [[Sulfadiazine indications and usage|Indications and Usage]]''' | ||
'''| [[Sulfadiazine contraindications|Contraindications]]''' | '''| [[Sulfadiazine contraindications|Contraindications]]''' | ||
'''| [[Sulfadiazine warnings and precautions|Warnings and Precautions]]''' | '''| [[Sulfadiazine warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[Sulfadiazine adverse reactions|Adverse Reactions]]''' | '''| [[Sulfadiazine adverse reactions|Adverse Reactions]]''' | ||
'''| [[Sulfadiazine dosage and administration|Dosage and Administration]]''' | '''| [[Sulfadiazine dosage and administration|Dosage and Administration]]''' | ||
'''| [[Sulfadiazine how supplied|How Supplied]]''' | '''| [[Sulfadiazine how supplied|How Supplied]]''' | ||
Revision as of 08:21, 9 January 2014
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Category
US Brand Names
SULFADIAZINE®
FDA Package Insert
Description | Clinical Pharmacology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Dosage and Administration | How Supplied | Labels and Packages
Mechanism of Action
The systemic sulfonamides are bacteriostatic agents having a similar spectrum of activity. Sulfonamides competitively inhibit bacterial synthesis of folic acid (pteroylglutamic acid) from aminobenzoic acid. Resistant strains are capable of utilizing folic acid precursors or preformed folic acid.[1]
References
- ↑ "SULFADIAZINE TABLET [EON LABS, INC.]". Text " accessdate" ignored (help)